The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
CCL
Vol.
30
No.
10
October 26, 2007
- Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting
- FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy
- Flavopiridol Plus Cisplatin Tested In Phase II Trial
- Trial Combines Drugs Against Blood Vessel Formation
- Bevacizumab And Irinotecan May Increase Survival Of GBM
- NCI Cooperative Group, Cancer Center Trials Listed
TCL
Vol.
33
No.
40
November 02, 2007
TCL
Vol.
33
No.
41
November 09, 2007
TCL
Vol.
33
No.
42
November 16, 2007
- CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.
- Guest Commentary: Donald Berry Finds Fundamental Flaws In Data Pooling Plan.
- ASCO To Open Abstracts To Everyone Prior To Annual Meeting.
- Amgen Web Site For Patients Goes Dark After Story In The Cancer Letter.
- NCI’s Hawk To Lead Prevention Division At M.D. Anderson.
TCL
Vol.
33
No.
43
November 23, 2007
CCL
Vol.
30
No.
11
November 30, 2007
- ASCO Expanding Tools To Improve Coordination Of Cancer Treatment
- PET Three Months After Therapy Provides Early Warning Of Need For Intervention
- Nexavar Approved For Patients With Inoperable Liver Cancer
- Erbitux Improves Survival In Advanced Colorectal Cancer
- Revlimid Plus Steroid Effective In Clinical Trial
- NCI-Approved Clinical Trials Begun At Groups, Centers
